FDA Faces More Tech Hurdles After Clearing AERs Backlog, And Congress Is Watching
This article was originally published in The Tan Sheet
Congressional scrutiny of FDA’s overall document management challenges is unlikely to let up despite the agency’s clearing of its adverse event reports backlog. Rep. Michael Burgess hit FDA’s document management practices hard during the first formal hearing on the 21sy Century Cures initiative.
You may also be interested in...
House Energy and Commerce committee says it’s committed to a bill to accelerate U.S. biomedical innovation before the next FDA user fee cycle, but the wide scope of needs and stakeholders may make crafting legislation challenging – never mind getting it passed.
Strategic plan says CDER will streamline its processes and may find activities that could be “cut altogether.”
The CIO will help develop policy to protect sensitive information while balancing individual privacy and security. FDA restructured the organization with a chief health informatics officer – focused on research, development, scientific computing and big data – and the CIO for software development and deployment, infrastructure and customer service.